SARS-CoV-2-specific immune response and the pathogenesis of COVID-19 E Gusev, A Sarapultsev, L Solomatina, V Chereshnev International journal of molecular sciences 23 (3), 1716, 2022 | 168 | 2022 |
Trehalolipid biosurfactants from nonpathogenic Rhodococcus actinobacteria with diverse immunomodulatory activities MS Kuyukina, IB Ivshina, TA Baeva, OA Kochina, SV Gein, ... New biotechnology 32 (6), 559-568, 2015 | 86 | 2015 |
Systemic inflammation: methodological approaches to identification of the common pathological process NV Zotova, VA Chereshnev, EY Gusev PLoS One 11 (5), e0155138, 2016 | 85 | 2016 |
Systemic inflammation and liver damage in HIV/hepatitis C virus coinfection KV Shmagel, EV Saidakova, NG Shmagel, LB Korolevskaya, ... HIV medicine 17 (8), 581-589, 2016 | 78 | 2016 |
Antinuclear autoantibodies in health: autoimmunity is not a synonym of autoimmune disease IA Pashnina, IM Krivolapova, TV Fedotkina, VA Ryabkova, ... Antibodies 10 (1), 9, 2021 | 69 | 2021 |
Immunological and pathophysiological mechanisms of systemic inflammation VA Chereshnev, EY Gusev Medical immunology 14 (1-2), 9-20, 2012 | 68 | 2012 |
Human immunodeficiency virus infection: from biological observations to mechanistic mathematical modelling G Bocharov, V Chereshnev, I Gainova, S Bazhan, B Bachmetyev, ... Mathematical Modelling of Natural Phenomena 7 (5), 78-104, 2012 | 66 | 2012 |
In vitro immunomodulating activity of biosurfactant glycolipid complex from Rhodococcus ruber MS Kuyukina, IB Ivshina, SV Gein, TA Baeva, VA Chereshnev Bulletin of Experimental Biology and Medicine 144, 326-330, 2007 | 61 | 2007 |
Feedback regulation of proliferation vs. differentiation rates explains the dependence of CD4 T-cell expansion on precursor number G Bocharov, J Quiel, T Luzyanina, H Alon, E Chiglintsev, V Chereshnev, ... Proceedings of the National Academy of Sciences 108 (8), 3318-3323, 2011 | 50 | 2011 |
Molecular bases of immune complex pathology KV Shmagel, VA Chereshnev Biochemistry (Moscow) 74, 469-479, 2009 | 48 | 2009 |
Immunology of inflammation: the role of cytokines VA Chereshnev, EY Gusev Medical immunology 3 (3), 361-8, 2001 | 45 | 2001 |
Problems of pathogenesis and pathogenetic therapy of COVID-19 from the perspective of the general theory of pathological systems (general pathological processes) E Gusev, A Sarapultsev, D Hu, V Chereshnev International journal of molecular sciences 22 (14), 7582, 2021 | 42 | 2021 |
Systemic inflammation: theoretical and methodological approaches to description of general pathological process model. Part 2. Evolution aspects E Gusev, VA Chereshnev Patologicheskaia fiziologiia i eksperimental'naia terapiia, 3-14, 2013 | 40 | 2013 |
A systems immunology approach to plasmacytoid dendritic cell function in cytopathic virus infections G Bocharov, R Züst, L Cervantes-Barragan, T Luzyanina, E Chiglintsev, ... PLoS Pathogens 6 (7), e1001017, 2010 | 38 | 2010 |
In vitro cytokine stimulation assay for glycolipid biosurfactant from Rhodococcus ruber: role of monocyte adhesion SV Gein, MS Kuyukina, IB Ivshina, TA Baeva, VA Chereshnev Cytotechnology 63, 559-566, 2011 | 37 | 2011 |
Mathematical model of the Tat-Rev regulation of HIV-1 replication in an activated cell predicts the existence of oscillatory dynamics in the synthesis of viral components VA Likhoshvai, TM Khlebodarova, SI Bazhan, IA Gainova, ... BMC genomics 15, 1-18, 2014 | 36 | 2014 |
Influence of hepatitis C virus coinfection on CD4+ T cells of HIV-infected patients receiving HAART KV Shmagel, EV Saidakova, LB Korolevskaya, NG Shmagel, ... Aids 28 (16), 2381-2388, 2014 | 32 | 2014 |
Pathogenesis and treatment of HIV infection: the cellular, the immune system and the neuroendocrine systems perspective VA Chereshnev, G Bocharov, S Bazhan, B Bachmetyev, I Gainova, ... International reviews of immunology 32 (3), 282-306, 2013 | 32 | 2013 |
The global response to the COVID-19 pandemic: how have immunology societies contributed? F Osier, JPY Ting, J Fraser, BN Lambrecht, M Romano, RT Gazzinelli, ... Nature Reviews Immunology 20 (10), 594-602, 2020 | 30 | 2020 |
The challenges of vaccine development against betacoronaviruses: antibody dependent enhancement and sendai virus as a possible vaccine vector TA Zaichuk, YD Nechipurenko, AA Adzhubey, SB Onikienko, ... Molecular Biology 54, 812-826, 2020 | 27 | 2020 |